Brief: Acurx Pharmaceuticals, Inc. Announces Reverse Stock Split
31/07/2025 15:12
Acurx Pharmaceuticals Inc ACXP.O: ACURX PHARMACEUTICALS, INC. ANNOUNCES REVERSE STOCK SPLIT ACURX PHARMACEUTICALS INC - APPROVES 1-FOR-20 REVERSE STOCK SPLIT Source text: ID:nPn84Zq4Fa Further company coverage: ACXP.O
Recent news on Acurx Pharmaceuticals
See all newsAcurx Pharmaceuticals Q1 net loss narrows as expenses fall
Brief: Acurx Pharmaceuticals To Discuss First Quarter 2026 Financial Results On May 12, 2026 Conference Call And Provide Business Update
Brief: Acurx Pharmaceuticals, Inc. Announces Closing Of Up To $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Acurx Pharmaceuticals Q4 net loss narrows on lower R&D spend
Acurx Pharma Q3 net loss narrows to $2 mln